⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KYMR News
Kymera Therapeutics, Inc. Common Stock
Kymera Therapeutics Announces Late-Breaking Oral Presentation of KT-621 Phase 1b Data at the American Academy of Dermatology (AAD) Annual Meeting
globenewswire.com
KYMR
Kymera Therapeutics Announces Late-Breaking Oral Presentation of KT-621 Phase 1b Data at the American Academy of Dermatology (AAD) Annual Meeting
globenewswire.com
KYMR
Global Powder Metallurgy Market to Reach USD 7.68 Billion by 2032, Growing at 12% CAGR as EV Manufacturing and Sustainable Metal Processing Expand
prnewswire.com
RIO
ATI
KYMR
Form 8-K
sec.gov
KYMR
Form 8-K
sec.gov
KYMR
Kymera Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
globenewswire.com
KYMR
Kymera Therapeutics to Participate in Upcoming March Investor Conferences
globenewswire.com
KYMR
Kymera Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
globenewswire.com
KYMR
Cancer Stress Protein Helps Tumors Hide From Immunity
prnewswire.com
PFE
BMY
KYMR
AGIO
BDTX
PRTA
IPSC-derived NK Cells Clinical Trial Pipeline Gains Momentum: 12+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
globenewswire.com
FATE
INDP
AMGN
NKTR
IBIO
TAK
SNY
INMB
CLMT
VERX
GTBP
BHVN
CHRS
GSK
BMY
MRK
ABBV
AZN
GILD
LLY
KYMR
REGN
SPRY